Cited by 477

Neurotrophins are required for nerve growth during development

Tucker, Kerry Lee, Meyer, Michael, Barde, Yves-Alain·2001·Nature Neuroscience

Abstract

Although the requirement of neurotrophins for the prevention of cell death in the peripheral nervous system is well established, their physiological involvement in nerve growth is still unclear. To address this question, we generated a mouse that expresses the green fluorescent protein in post-mitotic neurons, allowing the repeated visualization of all motor and sensory axons during development. We imaged the growth of these axons into the limb bud of day 10.5 embryos. Sensory axons, but rarely motor axons, were targeted to ectopically placed beads containing any of the neurotrophins NGF, BDNF, NT-3 or NT-4/5. Conversely, a combination of function-blocking monoclonal antibodies to NGF, BDNF and NT-3 dramatically inhibited elongation of both sensory and motor axons in the limb bud, indicating that the growth of mixed nerves is dependent upon neurotrophins during development.

Integrity signals

Registry

Crossref · 10.1038/82868

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Humanized tau models such as hTau feature age-dependent tau pathology, neuronal loss and memory deficits.

    “humanized tau models such as the hTau model comprising a P1-derived artificial chromosome (PAC) copy of the human MAPT gene locus in a murine Mapt KO background (Duff, Knight et al. 2000, Tucker, Meyer et al. 2001, Andorfer, Kress et al. 2003) also feature age-dependent tau pathology, neuronal loss and memory deficits (Andorfer, Kress et al. 2003, Andorfer, Acker et al. 2005, Polydoro, Acker et al”

    From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Tucker, Meyer et al. 2001

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Bibel, M. & Barde, Y.-A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14, 2920–2935 (2000). · DOI
  2. Gundersen, L. W. & Barrett, J. N. Neuronal chemotaxis: chick dorsal root axons turn towards high concentrations of nerve growth factor. Science 206, 1079–1080 (1979). · DOI
  3. Song, H. J., Ming, G. L. & Poo, M.-m. cAMP-induced switching in turning direction of nerve growth cones. Nature 388, 275–279 (1997). · DOI
  4. Ming, G., Lohof, A. M. & Zheng, J. Q. Acute morphogenic and chemotropic effects of neurotrophins on cultured embryonic Xenopus spinal neurons. J. Neurosci. 17, 7860–7871 (1997). · DOI
  5. Menesini Chen, M. G., Chen, J. S. & Levi-Montalcini, R. Sympathetic nerve fibers ingrowth in the central nervous system of neonatal rodent upon intracerebral NGF injections. Arch. Ital. Biol. 116, 53–84 (1978).
  6. Hoyle, G. W., Mercer, E. H., Palmiter, R. D. & Brinster, R. L. Expression of NGF in sympathetic neurons leads to excessive axon outgrowth from ganglia but decreased terminal innervation within tissues. Neuron 10, 1019–1034 (1993). · DOI
  7. Hassankhani, A. et al. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev. Biol. 169, 309–321 (1995). · DOI
  8. Albers, K. M., Wright, D. E. & Davis, B. M. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J. Neurosci. 14, 1422–1432 (1994). · DOI
  9. Albers, K. M. et al. Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J. Cell Biol. 134, 487–497 (1996). · DOI
  10. ElShamy, W. M., Linnarsson, S., Lee, K.-F., Jaenisch, R. & Ernfors, P. Prenatal and postnatal requirements of NT-3 for sympathetic neuroblast survival and innervation of specific targets. Development 122, 491–500 (1996). · DOI
  11. Patel, T. D., Jackman, A., Rice, F. L., Kucera, J. & Snider, W. D. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron 25, 345–357 (2000). · DOI
  12. Fagan, A. M. et al. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J. Neurosci. 16, 6208–6218 (1996). · DOI
  13. Binder, L. I., Frankfurter, A. & Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371–1378 (1985). · DOI · Paper page
  14. Harada, A. et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488–491 (1994). · DOI
  15. Moody, S. A., Quigg, M. S. & Frankfurter, A. Development of the peripheral trigeminal system in the chick revealed by an isotype-specific anti-beta-tubulin monoclonal antibody. J. Comp. Neurol. 279, 567–580 (1989). · DOI
  16. Morriss-Kay, G. M. in Essential Developmental Biology: A Practical Approach (eds. Stern, C. D. & Holland, P. W. H.) 55–66 (IRL, Oxford, 1993). · DOI
  17. Katz, L. C. Local circuitry of identified projection neurons in cat visual cortex brain slices. J. Neurosci. 7, 1223–1249 (1987). · DOI
  18. Theiler, K. The House Mouse: Development and Normal Stages from Fertilization to 4 Weeks of Age (Springer, Berlin, 1972).
  19. Ebens, A. et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17, 1157–1172 (1996). · DOI
  20. Frade, J. M. & Barde, Y.-A. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 20, 35–41 (1998). · DOI
  21. Maina, F., Hilton, M. C., Ponzetto, C., Davies, A. M. & Klein, R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 11, 3341–3350 (1997). · DOI
  22. Korsching, S. & Thoenen, H. in Methods in Enzymology: Peptide Growth Factors Vol. 147 (eds. Barnes, D. & Sirbasku, D. A.) Part B, 167–185 (Academic, New York, 1987). · DOI
  23. Gaese, F., Kolbeck, R. & Barde, Y.-A. Sensory ganglia require neurotrophin-3 early in development. Development 120, 1613–1619 (1994). · DOI
  24. Kolbeck, R., Bartke, I., Eberle, W. & Barde, Y.-A. Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J. Neurochem. 72, 1930–1938 (1999). · DOI
  25. Cohen, S., Levi-Montalcini, R. & Hamburger, V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc. Natl. Acad. Sci. USA 40, 1014–1018 (1954). · DOI
  26. Farinas, I., Wilkinson, G. A., Backus, C., Reichardt, L. F. & Patapoutian, A. Characterization of neurotrophin and Trk receptor functions in developing sensory ganglia: direct NT-3 activation of TrkB neurons in vivo. Neuron 21, 325–334 (1998). · DOI
  27. Martin-Zanca, D., Barbacid, M. & Parada, L. F. Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev. 4, 683–694 (1990). · DOI
  28. Phillips, H. S. & Armanini, M. P. Expression of the trk family of neurotrophin receptors in developing and adult dorsal root ganglion neurons. Phil. Trans. R. Soc. Lond. B Biol. Sci. 351, 413–416 (1996). · DOI
  29. Gallo, G., Lefcort, F. B. & Letourneau, P. C. The trkA receptor mediates growth cone turning toward a localized source of nerve growth factor. J. Neurosci. 17, 5445–5454 (1997). · DOI
  30. Dechant, G. & Barde, Y.-A. Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 7, 413–418 (1997). · DOI
  31. Yamashita, T., Tucker, K. L. & Barde, Y.-A. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24, 585–593 (1999). · DOI
  32. Bandtlow, C. E., Heumann, R., Schwab, M. E. & Thoenen, H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J. 891–899 (1987). · DOI
  33. Davies, A. M. et al. Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature 326, 353–358 (1987). · DOI
  34. Nosrat, C. A. & Olson, L. Brain-derived neurotrophic factor mRNA is expressed in the developing taste bud-bearing tongue papillae of rat. J. Comp. Neurol. 360, 698–704 (1995). · DOI
  35. Xue, Y. & Honig, M. G. Ultrastructural observations on the expression of axonin-1: implications for the fasciculation of sensory axons during axonal outgrowth into the chick hindlimb. J. Comp. Neurol. 408, 299–317 (1999). · DOI · Paper page
  36. Edwards, R. H., Rutter, W. J. & Hanahan, D. Directed expression of NGF to pancreatic β cells in transgenic mice leads to selective hyperinnervation of the islets. Cell 58, 161–170 (1989). · DOI
  37. Farinas, I., Yoshida, C. K., Backus, C. & Reichardt, L. F. Lack of neurotrophin-3 results in death of spinal sensory neurons and premature differentiation of their precursors. Neuron 17, 1065–1078 (1996). · DOI
  38. White, F. A. et al. Synchronous onset of NGF and TrkA survival dependence in developing dorsal root ganglia. J. Neurosci. 16, 4662–4672 (1996). · DOI
  39. Wright, E. M., Vogel, K. S. & Davies, A. M. Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival. Neuron 9, 139–150 (1992). · DOI
  40. O'Connor, R. & Tessier-Lavigne, M. Identification of maxillary factor, a maxillary process-derived chemoattractant for developing trigeminal sensory axons. Neuron 24, 165–178 (1999). · DOI
  41. Rudnicki, M. A., Braun, T., Hinuma, S. & Jaenisch, R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71, 383–390 (1992). · DOI
  42. Tucker, K. L. et al. Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev. 10, 1008–1020 (1996). · DOI
  43. Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
  44. Hogan, B., Beddington, R., Costantini, F. & Lacy, E. Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Press, Cold Spring Harbor, New York, 1994).
  45. Bibel, M., Hoppe, E. & Barde, Y.-A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 18, 616–622 (1999). · DOI
  46. Hotary, K. B., Landmesser, L. T. & Tosney, K. W. Embryo slices. Methods Cell Biol. 51, 109–124 (1996). · DOI
  47. Gotz, R., Kolbeck, R., Lottspeich, F. & Barde, Y.-A. Production and characterization of recombinant mouse neurotrophin-3. Eur. J. Biochem. 204, 745–749 (1992). · DOI
  48. Evan, G. I., Lewis, G. K., Ramsay, G. & Bishop, J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biol. 5, 3610–3616 (1985). · DOI
  49. Frade, J. M. & Barde, Y.-A. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 126, 683–690 (1999). · DOI

Cited by

Sorted by citations

Authors
Tucker, K. L., Meyer, M., & Barde, Y.-A.
Venue
Nature Neuroscience
Published
2001-01
Volume
4
Issue
1
Pages
29-37
ISSN
  • 1097-6256
  • 1546-1726
Cited by
477
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review